Athersys plans to raise $20 million via stock sale

Athersys Inc. of Cleveland, a developer of adult stem cell therapies, plans to raise $20 million by issuing new shares, primarily to existing investors.

http://www.crainscleveland.com/article/20131202/FREE/131209966?CSAuthResp=1%3A373520456384033%3A168216%3A4%3A24%3Aapproved%3A77FBD1A7D58A86BB121E97E79B94EF7C